BioAdvance News

QR Pharma and UCLA Awarded $3 Million USARMY Grant to Test Posiphen® in Rat Models of Concussion and Blunt Head Trauma

By WebmasterOctober 9, 2013November 1st, 2024No Comments

QR Pharma and UCLA Awarded $3 Million USARMY Grant to Test Posiphen® in Rat Models of Concussion and Blunt Head Trauma
Read more here

Previous PostUSciences Gets into the Biotech Biz
Next PostThe Future of Drug Discovery: Two Required Supplements to Current Practices